[Lamivudine therapy for prevention of chemotherapy-induced reactivation of hepatitis B virus].
Jia
Jie
J
Research Unit of Tropical Medicine, Hainan Provincial People's Hospital, Haikou 570311, China.
Lin
Feng
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D055502:Secondary Prevention; D013274:Stomach Neoplasms / Q000188:drug therapy
D000998:Antiviral Agents; D019259:Lamivudine